What You Should Know:
- Asensus Surgical, Inc. (NYSE American: ASXC), a leading developer of digital surgical technologies, announced today it has entered into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., a subsidiary of the global medical technology company KARL STORZ SE & Co. KG.
- Asensus Surgical is a pioneer in digital surgery, developing the first intra-operative Augmented Intelligence technology approved for global use. Their LUNA system,
Read More
Most Popular
Nearly 70% of High-Risk Patients Unaware of Chronic Kidney Disease Risk, Study Finds
What You Should Know:
- A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal of Accountable Care, the research highlights the importance of patient-provider communication and patient activation in early detection and prevention of CKD, a leading cause of death in the United States.
- The research emphasizes the value of patient education and
Read More
Blood Test for Alzheimer’s on the Horizon: ALZpath Licenses pTau217 Antibody to Roche
What You Should Know:
- ALZpath, a leader in Alzheimer's disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer's disease using Roche's widely used Elecsys® platform.
- The Roche pTau217 test has already received Breakthrough Device designation from the FDA and will be commercialized as part of a collaboration between Roche and Eli Lilly.
pTau217: A Game Changer in
Read More
Waste Management Acquires Stericycle in $7.2B Deal
What You Should Know:
- Waste Management, Inc. (NYSE: WM) and Stericycle (NASDAQ: SRCL) announced today a definitive agreement for WM to acquire Stericycle for $62.00 per share in cash.
- This translates to a total enterprise value of approximately $7.2B, including Stericycle's net debt of $1.4B. The offer represents a 24% premium over Stericycle's 60-day volume-weighted average stock price before a potential sale was reported publicly.
Stericycle: A Leading Player in
Read More
Weave Bio Launches for AI-Powered Drug Development, Secures $10M
What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
How Connected Healthcare Operations Helps Health Systems Work Smarter, Not Harder
When it comes to healthcare, efficiency isn’t just a goal—it’s a lifeline. With a growing and aging patient population and widespread workforce shortages, hospitals and health systems must find ways to increase efficiencies and do more with less, while providing safe, high-quality care. This starts with liberating data and connecting healthcare operations solutions across the enterprise.
The Epidemic of Siloed Data
The volume of healthcare data is growing exponentially, with a
Read More
CVS + Echo Health Makes Strategic Investment in Thyme Care
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health Ventures. Both partners have identified Thyme Care’s provider-centric approach as the only way to improve the patient experience and reduce costs across the care continuum. The investment was part of Thyme’s Series B fundraise.
- The strategic funding will fuel the national expansion of Thyme Care's innovative model, aiming to improve
Read More
Redox, Snowflake Partner to Streamline Healthcare Data Exchange for AI and Machine Learning
What You Should Know:
- Redox, a healthcare interoperability company, and Snowflake, the Data Cloud company, have joined forces to simplify the exchange of healthcare data.
- This strategic partnership aims to revolutionize how healthcare organizations access and utilize patient data, ultimately leading to improved patient care.
Unifying Legacy Systems for Seamless Data Flow
The collaboration leverages Redox's expertise in unifying healthcare data from various sources,
Read More
Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine
What You Should Know:
- Tempus AI, a leader in artificial intelligence (AI)-powered precision medicine, filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO). Industry analysts, however, believe this figure might be a placeholder, with the actual target amount closer to $600M.
- Founded in 2015 and headquartered in Chicago, Illinois, Tempus AI reported $562M in revenue for the fiscal year ending March 31,
Read More
ONC Brief Reveals Current State of Hospital Data Interoperability
What You Should Know:
- A new report by the Office of the National Coordinator for Health Information Technology (ONC) examines the current state of electronic health information exchange among hospitals in the United States. The findings reveal progress in interoperability but also highlight areas where improvement is needed.
- In addition, this brief describes the breadth of electronic information exchange between hospitals and other providers across the care continuum
Read More
